Name: UMIN ID:
Unique ID issued by UMIN | C000000022 |
---|---|
Receipt number | R000000030 |
Scientific Title | Capecitabine/cyclophosphamide combination therapy for patients with advanced or metastatic breast cancer who have been previously treated with anthracyclines - a phase 2 study |
Date of disclosure of the study information | 2005/07/07 |
Last modified on | 2011/07/26 11:25:05 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/07/07 16:06:52 | ||
2 | Update | 2005/07/08 09:20:06 | Organization Division name Division name Organization |
|
3 | Update | 2006/02/03 11:10:31 | Category of Funding Organization |
|
4 | Update | 2006/02/03 13:02:13 | Interventions/Control_1 Interventions/Control_1 |
|
5 | Update | 2006/08/08 11:05:16 | Organization |
|
6 | Update | 2007/02/03 09:52:02 | Last follow-up date |
|
7 | Update | 2007/04/07 10:28:54 | Email1 |
|
8 | Update | 2007/04/07 10:33:15 | Division name |
|
9 | Update | 2008/01/08 09:03:36 | Recruitment status |
|
10 | Update | 2008/07/07 09:48:12 | Publication of results |
|
11 | Update | 2008/12/16 16:20:21 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
12 | Update | 2011/04/09 12:09:20 | Name of person sending information Organization Division name Address |
|
13 | Update | 2011/04/09 12:09:45 | Publication of results |
|
14 | Update | 2011/07/26 11:25:05 | Post marketing survey by drug manufacture etc., specified by Japanese law. |